Laxative pills

Product NDC
55910-245
Requested package NDC
55910-245-48
11-digit product format
559100245
Labeler code
55910
Product ID
55910-245_e49e6de1-060f-4b2f-a111-471abc2da551
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides
Dosage form
TABLET
Route
ORAL
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2013-12-30
Marketing end
0000-00-00
Substance
SENNOSIDES
Active strength
25 mg/1
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage55910-24555910-245-48DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage55910-24555910-245-48DDiscontinued by firmexcluded / ndc_excluded.zipd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage55910-24555910-245-48DDiscontinued by firmexcluded / ndc_excluded.zipf5e01cc5f278…a2eaf40c39c3…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55910-245-482021-10-19C16284748780-1ba0f9c33-34fb-a910-e053-dadaa90a0b85Drug Facts
55910-245-482021-01-29C16284748780-1ba0f9c33-34fb-a910-e053-dadaa90a0b85Drug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SENNOSIDESACTIVE INGREDIENT3FYP5M0IJXLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
SENNOSIDESACTIVE MOIETY3FYP5M0IJXLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
ACACIAINACTIVE INGREDIENT5C5403N26OLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
AMMONIAINACTIVE INGREDIENT5138Q19F1XLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEPLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CALCIUM SULFATE ANHYDROUSINACTIVE INGREDIENTE934B3V59HLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M416302LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
KAOLININACTIVE INGREDIENT24H4NWX5COLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ALAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
POVIDONESINACTIVE INGREDIENTFZ989GH94ELAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
SHELLACINACTIVE INGREDIENT46N107B71OLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
SUCROSEINACTIVE INGREDIENTC151H8M554LAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
TALCINACTIVE INGREDIENT7SEV7J4R1ULAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
TARTARIC ACIDINACTIVE INGREDIENTW4888I119HLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2
WHITE WAXINACTIVE INGREDIENT7G1J5DA97FLAXATIVE PILLS MAXIMUM STRENGTH (SENNOSIDES) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55910-245-48559100245484 BLISTER PACK in 1 CARTON (55910-245-48) > 12 TABLET in 1 BLISTER PACK4 blister pack2013-12-300000-00-00NoNoCurrent